Compare AbCellera Biologics Inc (ABCL) vs Vanguard S&P 500 ETF (VOO) Price & Performance

AbCellera Biologics IncTrade

Vanguard S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Vanguard S&P 500 ETF — how do they compare? AbCellera Biologics Inc trades at $9.53 (market cap $2.99B), while Vanguard S&P 500 ETF trades at $710.38. Which is the better fit depends on your goals.

	ABCL	VOO
Market Cap	$2.99B	—
Sector	Health	Broad Market / Factor
52-Week High	$9.76	$710.71
52-Week Low	$2.78	$580.93
Enterprise Value	$2.58B	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbCellera Biologics Inc

AbCellera Biologics (ABCL) surged 34.78% to $9.34, driven by positive Phase 2 trial results for its menopause drug ABCL635. Despite negative net income margins and cash burn, analyst consensus is strongly bullish with a $15.50 price target. The stock shows a bullish technical trend, with support at $8 and resistance at $10, though RSI levels indicate overbought conditions.

The outlook hinges on ABCL635's clinical progress and future revenue potential, but high valuation ratios and persistent losses pose significant risks. Investor sentiment is optimistic due to recent drug trial success, yet the company must demonstrate a path to profitability to justify current market enthusiasm.

Vanguard S&P 500 ETF

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABCL

View details →

VOO

Fidelity's zero-fee fund challenges Vanguard's S&P 500 ETF but offers limited gains for taxable accounts.24/7 Wall Street · 1 day agoNeutral Vanguard High Dividend Yield ETF lags S&P 500 by $141K over 10 years despite dividends.24/7 Wall Street · 1 day agoBearish Vanguard's S&P 500 ETF (VOO) offers cheaper, more flexible access than the mutual fund VFIAX.24/7 Wall Street · 3 days agoBullish View details →

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

About Vanguard S&P 500 ETF

VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.